نتایج جستجو برای: cmt1a

تعداد نتایج: 183  

2012
Young Hwa Kim Hwa Kyung Chung Kee Duk Park Kyoung-Gyu Choi Seung-Min Kim Il-Nam Sunwoo Young-Chul Choi Jeong-Geun Lim Kwang Woo Lee Kwang-Kuk Kim Dong Kuk Lee In Soo Joo Ki-Han Kwon Seok Beom Gwon Jae Hyeon Park Dae-Seong Kim Seung Hyun Kim Woo-Kyung Kim Bum Chun Suh Sang-Beom Kim Nam-Hee Kim Eun Hee Sohn Ok-Joon Kim Hyun Sook Kim Jung Hee Cho Sa-Yoon Kang Chan-Ik Park Jiyoung Oh Jong Hyu Shin Ki Wha Chung Byung-Ok Choi

BACKGROUND AND PURPOSE Charcot-Marie-Tooth disease (CMT) type 1A (CMT1A) is the demyelinating form of CMT that is significantly associated with PMP22 duplication. Some studies have found that the disease-related disabilities of these patients are correlated with their compound muscle action potentials (CMAPs), while others have suggested that they are related to the nerve conduction velocities....

2017
Jingwen Niu Liying Cui Mingsheng Liu

INTRODUCTION Multiple sites measurement of cross-sectional areas (CSA) by ultrasound was performed to differentiate Charcot-Marie-Tooth type 1A (CMT1A) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). METHODS Nine patients with CMT1A, 28 patients with CIDP, and 14 healthy controls (HC) were recruited prospectively. Consecutive ultrasonography scanning was performed from w...

Journal: :Clinical chemistry 2001
J L Badano K Inoue N Katsanis J R Lupski

BACKGROUND Charcot-Marie-Tooth disease type 1A (CMT1A) accounts for 70-90% of cases of CMT1 and is most frequently caused by the tandem duplication of a 1.4-Mb genomic fragment on chromosome 17p12. Molecular diagnosis of CMT1A has been based primarily on pulsed-field electrophoresis, fluorescence in situ hybridization, polymorphic allele dosage analysis, and quantitative PCR. We sought to impro...

Journal: :Clinical chemistry 2000
C Ruiz-Ponte L Loidi A Vega A Carracedo F Barros

BACKGROUND Current methods to determine gene dosage are time-consuming and labor-intensive. We describe a new and rapid method to assess gene copy number for identification of DNA duplications or deletions occurring in Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP), respectively. METHODS We studied 16 patients with HNPP, 4 with ...

2016
Soo Hyun Nam Young Bin Hong Young Se Hyun Da Eun Nam Geon Kwak Sun Hee Hwang Byung-Ok Choi Ki Wha Chung

Inherited peripheral neuropathies (IPN), which are a group of clinically and genetically heterogeneous peripheral nerve disorders including Charcot-Marie-Tooth disease (CMT), exhibit progressive degeneration of muscles in the extremities and loss of sensory function. Over 70 genes have been reported as genetic causatives and the number is still growing. We prepared a targeted gene panel for IPN...

Journal: :Journal of medical genetics 1992
J C MacMillan M Upadhyaya P S Harper

The gene for Charcot-Marie-Tooth disease type 1a (CMT1a) has been localised to chromosome 17p11.2. Locus D17S122 is recognised by the DNA probe pVAW409R3 which detects an MspI polymorphism with three alleles in the normal population. Subjects with CMT1a show evidence of trisomy for this region of chromosome 17 by displaying either all three alleles or a dosage effect when only two alleles are p...

Journal: :Neurology 2015
Nina Hirt Katja Eggermann Sonja Hyrenbach Johann Lambeck Andreas Busche Judith Fischer Sabine Rudnik-Schöneborn Harald Gaspar

Charcot-Marie-Tooth disease type 1 A (CMT1A, OMIM #118220) and hereditary neuropathy with liability to pressure palsies (HNPP or tomaculous neu-ropathy, OMIM #162500) are autosomal dominantly inherited neuropathies caused by genomic rearrangements on chromosome 17p11.2-p12 containing PMP22. Heterozygous PMP22 duplications result in a peripheral neuropathy characterized by distal muscular atroph...

2014
Ilya Chumakov Aude Milet Nathalie Cholet Gwenaël Primas Aurélie Boucard Yannick Pereira Esther Graudens Jonas Mandel Julien Laffaire Julie Foucquier Fabrice Glibert Viviane Bertrand Klaus-Armin Nave Michael W Sereda Emmanuel Vial Mickaël Guedj Rodolphe Hajj Serguei Nabirotchkin Daniel Cohen

Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited sensory and motor peripheral neuropathy. It is caused by PMP22 overexpression which leads to defects of peripheral myelination, loss of long axons, and progressive impairment then disability. There is no treatment available despite observations that monotherapeutic interventions slow progression in rodent models. We thus h...

Journal: :Journal of medical genetics 1995
C Cudrey C Chevillard D Le Paslier A Vignal E Passage M Fontes

Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of the peripheral hereditary neuropathies, has been associated with a duplication of a genomic segment of 1.5 Mb, located in 17p11.2. Recently, the same segment has been found to be deleted in patients with another peripheral neuropathy, hereditary neuropathy with liability to pressure palsies (HNPP). Highly polymorphic marker...

2017
Wenjia Wang Mickaël Guedj Viviane Bertrand Julie Foucquier Elisabeth Jouve Daniel Commenges Cécile Proust-Lima Niall P Murphy Olivier Blin Laurent Magy Daniel Cohen Shahram Attarian

The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring disease severity and progression in CMT1A patients has been questioned. Here, we applied a Rasch analysis in a French cohort of patients to evaluate the psychometrical pro...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید